How would you approach a patient with Gleason 9 prostate cancer and regional lymphadenopathy as well as inguinal lymphadenopathy (M1a) but no bone metastases?   

Would you offer definitive management with radiation and ADT? Or systemic therapy alone such as with ADT+abiraterone?

Answer from: Radiation Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice